Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 6Active not recruiting 5Completed 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 30Magnetic Resonance Spectroscopy 21Biopsy 21Cyclophosphamide 8venetoclax 5Taxes 5Bevacizumab 5X-Rays 4Vincristine 4Surgical Procedures, Operative 4Nivolumab 4Etoposide 4Cetuximab 4Azacitidine 4fludarabine phosphate 3fludarabine 3decitabine and cedazuridine drug combination 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Radiation 3Prednisone 3Immunoglobulin G 3Gemcitabine 3Doxorubicin 3Disulfides 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3zanubrutinib 2trastuzumab deruxtecan 2prednylidene 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Diet Therapy × 90 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡